First-in-human study of SAR443765 in healthy participants and in asthmatic participants

Trial Identifier:	PDY16622
Sponsor:	Sanofi
Start Date:	June 2022
Primary Completion Date:	February 2023
Study Completion Date:	February 2023
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GERMANY	berlin, GERMANY
UNITED KINGDOM	Belfast, UNITED KINGDOM, BT9 6AD

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.